Published in Palliat Med on January 01, 1999
Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem (1977) 5.09
Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol (2008) 3.44
Traffic related pollution and heart rate variability in a panel of elderly subjects. Thorax (2005) 3.12
Climate response times: dependence on climate sensitivity and ocean mixing. Science (1985) 3.09
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2009) 2.73
Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol (2000) 2.67
Care of dying patients in hospital. Things have improved. BMJ (1994) 2.41
Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ (1999) 2.21
A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med (2001) 2.20
Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol (1999) 2.16
Poly(ADP-ribose) and ADP-ribosylation of proteins. Rev Physiol Biochem Pharmacol (1976) 2.08
Non-pharmacological intervention for breathlessness in lung cancer. Palliat Med (1996) 1.99
Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status. Ann Oncol (2006) 1.85
Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979. Circulation (1982) 1.67
Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia (2000) 1.55
Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer (1999) 1.52
Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol (2001) 1.52
A comparison of the characteristics of disease-free breast cancer survivors with or without cancer-related fatigue syndrome. Eur J Cancer (2008) 1.52
Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J (1992) 1.45
Outcome and predictive factors of local recurrence and distant metastases following primary surgical treatment of high-grade malignant phyllodes tumours of the breast. Eur J Surg Oncol (2001) 1.45
Differences in tests of aniseikonia. Invest Ophthalmol Vis Sci (1992) 1.44
A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain. J Pain Symptom Manage (2001) 1.44
The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia (1988) 1.41
A cut above: the rising Caesarean section rate in New Zealand. N Z Med J (1998) 1.40
Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol (2009) 1.40
Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy. Breast Cancer Res Treat (1998) 1.39
Should obesity be treated? Patients with sleep apnoea should be treated. BMJ (1994) 1.39
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39
A more rational basis for determining the activities used for radionuclide imaging? Eur J Nucl Med (1997) 1.37
A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Ann Oncol (2008) 1.35
Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer (1999) 1.28
A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol (2000) 1.27
How common is fatigue in disease-free breast cancer survivors? A systematic review of the literature. Breast Cancer Res Treat (2007) 1.25
Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer (2000) 1.23
Psychopathology in the parents of children with conduct disorder and hyperactivity. J Am Acad Child Adolesc Psychiatry (1988) 1.17
Attenuation of nocturnal asthma by cromakalim. Lancet (1990) 1.15
A novel system for investigating the ability of smooth muscle cells and fibroblasts to regulate adhesion of flowing leukocytes to endothelial cells. J Immunol Methods (2001) 1.13
Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. Br J Surg (2004) 1.12
Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible? Fertil Steril (2000) 1.12
The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. BMJ (2001) 1.11
Diagnostic precision of CT in local staging of colon cancers: a meta-analysis. Clin Radiol (2010) 1.08
Measurement of anterior-posterior displacement of the knee. A comparison of the results with instrumented devices and with clinical examination. J Bone Joint Surg Am (1990) 1.08
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 cases. Cancer (1999) 1.08
Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer (2000) 1.07
Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin. Br J Cancer (2012) 1.06
A cost-benefit analysis of intensive therapy. Anaesthesia (1993) 1.05
Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer. Br J Cancer (2012) 1.04
Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer (1992) 1.03
Sound frequency analysis and the site of snoring in natural and induced sleep. Clin Otolaryngol Allied Sci (2002) 1.01
Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev (2008) 1.01
Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage (2001) 1.01
The pathogenesis of dysplastic kidney in a urinary tract obstruction in the female fetal lamb. J Pediatr Surg (1999) 1.01
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer. Br J Cancer (2004) 0.99
The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med (1998) 0.99
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. Br J Cancer (2010) 0.99
Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. Br J Surg (2004) 0.98
Nutrition, dehydration and the terminally ill. J Med Ethics (1995) 0.97
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer. Int J Cancer (1997) 0.97
Nasal resistance in obstructive sleep apnea. Chest (1994) 0.96
Medullary thyroid cancer: multivariate analysis of prognostic factors influencing survival. Eur J Surg Oncol (2000) 0.96
The activity of single-agent carboplatin in advanced seminoma. Eur J Cancer (1992) 0.94
Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer. Ann Oncol (2014) 0.94
Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer. Oral Oncol (1998) 0.94
Evidence-based practice: the past, the present, and recommendations for the millennium. Pediatr Nurs (2002) 0.92
Do oral appliances enlarge the airway in patients with obstructive sleep apnoea? A prospective computerized tomographic study. Eur J Orthod (2000) 0.92
Use of amantadine in Parkinson's disease. Results of a double-blind trial. Br Med J (1970) 0.92
The role of radiotherapy in the management of elevated calcitonin after surgery for medullary thyroid cancer. Thyroid (2001) 0.91
Clinical presentation and long-term outcome of pure myoepithelial carcinoma of the breast. Eur J Surg Oncol (2004) 0.91
Mucosal malignant melanoma of the head and neck: the Marsden experience over half a century. Clin Oncol (R Coll Radiol) (2003) 0.90
Time-related effects of estrogen withdrawal on proliferation- and cell death-related events in MCF-7 xenografts. Int J Cancer (1999) 0.89
Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol (1998) 0.89
The incidence of hyperemesis gravidarum is increased among Pacific Islanders living in Wellington. N Z Med J (1995) 0.89
Thyroid cancer in children: the Royal Marsden Hospital experience. Eur J Cancer (2000) 0.87
Outcome of malignant spinal cord compression at a cancer center: implications for palliative care services. J Pain Symptom Manage (2000) 0.87
A community outbreak of Salmonella berta associated with a soft cheese product. Epidemiol Infect (1998) 0.87
Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer. Ann Oncol (2012) 0.87
Prediction of survival in a hospital-based continuing care unit. Eur J Cancer (1994) 0.86
Psychological Correlates of Mental Stress-induced Ischemia in the Laboratory: The Psychophysiological Investigation of Myocardial Ischemia (PIMI) Study. J Health Psychol (2000) 0.86
Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer. Int J Gynecol Cancer (2004) 0.85
The role of genetic factors in predisposition to squamous cell cancer of the head and neck. Br J Cancer (1999) 0.85
The use of the Rotterdam Symptom Checklist in palliative care. J Pain Symptom Manage (1999) 0.85
Good manners for the pharmaceutical industry. Lancet (1997) 0.85
IL-6, TNFalpha and TGFbeta promote nonapoptotic trophoblast deportation and subsequently causes endothelial cell activation. Placenta (2009) 0.85
Cationic neutrophil proteins increase transendothelial albumin movement. J Appl Physiol (1985) (1987) 0.85
Gestational trophoblastic disease with liver metastases: the Charing Cross experience. Br J Obstet Gynaecol (1997) 0.85
A role for interleukin-6 in spreading endothelial cell activation after phagocytosis of necrotic trophoblastic material: implications for the pathogenesis of pre-eclampsia. J Pathol (2009) 0.85
A prevalence study of errors in opioid prescribing in a large teaching hospital. Int J Clin Pract (2011) 0.84
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma. Ann Oncol (2009) 0.83
New insights into p53 protein stabilisation in oral squamous cell carcinoma. Oral Oncol (1999) 0.83
A cost-utility analysis of intensive therapy. II: Quality of life in survivors. Anaesthesia (1994) 0.83
The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer. Br J Cancer (1999) 0.83
Nebulized frusemide for dyspnoea. Palliat Med (1994) 0.83
Phagocytosis of apoptotic trophoblastic debris protects endothelial cells against activation. Placenta (2012) 0.82
Biochemical/immunologic markers of emphysema. Ann N Y Acad Sci (1991) 0.82
Using an interactive video disk in breast cancer patient support. Nurs Times (1999) 0.82
Elastase release of basic fibroblast growth factor in pulmonary fibroblast cultures results in down-regulation of elastin gene transcription. A role for basic fibroblast growth factor in regulating lung repair. J Biol Chem (1996) 0.82
Prognosticating in patients with advanced cancer--observational study comparing the accuracy of clinicians' and patients' estimates of survival. Ann Oncol (2012) 0.81
Association between polymorphisms of the GPX1 gene and second primary tumours after index squamous cell cancer of the head and neck. Oral Oncol (2005) 0.81
A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma. Eur J Cancer (1994) 0.81